BTLA Antikörper (AA 101-150)
-
- Target Alle BTLA Antikörper anzeigen
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Bindungsspezifität
- AA 101-150
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BTLA Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
- Immunogen
- Synthetic peptide from Human protein at AA range: 101-150
- Isotyp
- IgG
- Top Product
- Discover our top product BTLA Primärantikörper
-
-
- Applikationshinweise
- IHC:1:50-300, ELISA:1:10000-20000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, containing 0.02 % sodium azide as Preservative and 50 % Glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Andere Bezeichnung
- BTLA (BTLA Produkte)
- Hintergrund
- B and T lymphocyte associated protein antibody, B and T lymphocyte attenuator antibody, B and T lymphocyte associated antibody, B- and T-lymphocyte attenuator antibody, B- and T-lymphocyte-associated protein antibody, BTLA antibody, BTLA_HUMAN antibody, BTLA1 antibody, CD272 antibody, CD272 antigen antibody, FLJ16065 antibody, MGC129743 antibody
- UniProt
- Q7Z6A9
- Pathways
- Cancer Immune Checkpoints
-